News

Cañon City Daily Record1h
The world’s only twice-a-year shot to prevent HIV could stop transmission — if people can get it
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated ...
News On 61h
FDA approves new, twice-yearly injection for HIV prevention
The FDA announced today that they've approved a twice-yearly injection for preventing HIV infection in adults and kids. News ...
FDA approves powerful HIV drug that nearly eliminated spread in clinical trials
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
mlive6h
Genesee County offers no-cost HIV testing at June 27 event in Flint
The Genesee County Health Department is offering no-cost testing during National HIV Testing Day at the Genesee Free Medical ...
Newser on MSN6h
FDA Approves Shot to Prevent HIV Needed Just Twice a Year
A new HIV prevention shot that requires just two injections a year has received FDA approval after clinical trials showed it ...
FDA approves 6-month HIV prevention shot
Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more ...
The Well News on MSN7h
FDA Approves Gilead's Twice-Yearly Injection for HIV Prevention
WASHINGTON - The Food and Drug Administration on Wednesday approved Gilead Sciences' lenacapavir, a twice-yearly injection ...
STAT9h
HIV protection with just two shots a year: FDA approves Gilead drug
A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
The launch of the injection faces potential threats, including the Trump administration’s proposed cuts to federal funding ...
FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...